Codexis (CDXS) Tops Q2 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/27/2026
- Wall Street ends mixed as investors focus on tech earnings
- Nvidia in talks with OpenAI to guarantee $250 billion financing for data center, WSJ reports
- ASML and U.S. chip stocks sink on report of China’s DUV breakthrough
- Why is Bernstein bullish on memory stocks after Samsung, Nvidia deals?
- Oil prices settle at lowest in over a week, as US pauses attacks on Iran
- BTIG Upgrades Outlook Therapeutics Inc. (OTLK) to Buy
- Carpenter Technology CEO Brian Malloy passes; Tony Thene returns as CEO
- ASML and U.S. chip stocks sink on report of China’s DUV breakthrough
- Wall Street ends mixed as investors focus on tech earnings
- Nvidia in talks with OpenAI to guarantee $250 billion financing for data center, WSJ reports
Stifel on Codexis, Inc. (CDXS): 'Key Milestones On the Horizon in 2H25'
August 14, 2025 10:35 AM EDTStifel analyst Daniel Arias reiterated a Buy rating and $5.00 price target on Codexis, Inc. (NASDAQ: CDXS).
The analyst comments "CDXS beat consensus on revs and provided a briefing on the encouraging status of the Pharma Biocatalysis business and the ECO Synthesis... More
